Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,103,477 articles, preprints and more)

Search results

1-25 of 286 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

A model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaques.
Wu HL, Weber WC, Waytashek CM, Boyle CD, Reed JS, Bateman KB, Fisher HK, Chen Y, Armantrout K, Swanson T, Shriver-Munsch C, Northrup M, Fischer M, Biswas S, Templon J, Panoskaltsis-Mortari A, Burwitz BJ, Johnson AL, Colgin L, [...] Sacha JB
PLoS Pathog, 20(11):e1012644, 11 Nov 2024
Cited by: 0 articles | PMID: 39527641
Add to export list
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.
Khare S, Williamson S, O'Barr B, Schachter L, Chen A, Hayes-Lattin B, Leonard J, Desai A, Ferreira-Gandolfo P, Christmas K, Lackey D, Maziarz RT, Nemecek ER
Clin Lymphoma Myeloma Leuk, S2152-2650(24)02355-3, 27 Sep 2024
Cited by: 0 articles | PMID: 39426942
Add to export list
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel.
Ahmed N, Wesson W, Lutfi F, Porter DL, Bachanova V, Nastoupil LJ, Perales MA, Maziarz RT, Brower J, Shah GL, Chen AI, Oluwole OO, Schuster SJ, Bishop MR, McGuirk JP, Riedell PA
Blood Adv, 8(20):5346-5354, 01 Oct 2024
Cited by: 1 article | PMID: 39042880 | PMCID: PMC11568755
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
"Don't keep me waiting": estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes.
Vadgama S, Pasquini MC, Maziarz RT, Hu ZH, Ray M, Smith H, Bullement A, Edmondson-Jones M, Sullivan W, Cartron G
Blood Adv, 8(13):3519-3527, 01 Jul 2024
Cited by: 0 articles | PMID: 38662645 | PMCID: PMC11261112
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience and Literature Review.
Niehus HD, Sabile J, Maziarz RT, Meyers G, Cook R, Gandhi AP, Saultz JN, Rakshe S, Kaempf A, Braun T, Migdady Y
Acta Haematol, 1-10, 26 Jun 2024
Cited by: 0 articles | PMID: 38934131
Add to export list
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation.
Iqbal M, Kumar A, Dreger P, Chavez J, Sauter CS, Sureda AM, Bachanova V, Maziarz RT, Dreyling M, Smith SM, Jacobson C, Glass B, Casulo C, Oluwole OO, Montoto S, Advani R, Cohen J, Salles G, Hamad N, [...] Kharfan-Dabaja MA
Transplant Cell Ther, 30(9):832-843, 06 Jul 2024
Cited by: 0 articles | PMID: 38972511
Add to export list
The rationale behind grafting haploidentical hematopoietic stem cells.
Maziarz RT, Cook RJ
Hematology, 29(1):2347673, 07 May 2024
Cited by: 0 articles | PMID: 38712914
Add to export list Review
Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective.
Maziarz RT, Gergis U, Edwards ML, Song Y, Liu Q, Anderson A, Signorovitch J, Manghani R, Simantov R, Shin H, Sivaraman S
Blood Adv, 8(5):1200-1208, 01 Mar 2024
Cited by: 1 article | PMID: 38055922
Add to export list
CAR T-Cell Immunotherapy in Minority Patients with Lymphoma.
Ghilardi G, Williamson S, Pajarillo R, Paruzzo L, Chen L, Grady C, Doucette A, Nemecek E, Gabrielli G, Barta SK, Svoboda J, Chong EA, Yelton R, Nasta SD, Landsburg DJ, Ugwuanyi O, Chen AI, Schachter L, White G, [...] Ruella M
NEJM Evid, 3(4):EVIDoa2300213, 26 Mar 2024
Cited by: 0 articles | PMID: 38776868
Add to export list
The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients.
De Sa H, Maziarz RT, Gandhi AP
Expert Opin Biol Ther, 24(3):139-146, 14 Mar 2024
Cited by: 0 articles | PMID: 38481366
Add to export list Review
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study.
McCarthy PL, Attwood KM, Liu X, Chen GL, Minderman H, Alousi A, Bashey A, Lowsky R, Miklos DB, Hansen J, Westervelt P, Yanik G, Waller EK, Howard A, Blazar BR, Wallace PK, Reshef R, Horowitz MM, Maziarz RT, [...] Mohammadpour H
Bone Marrow Transplant, 59(3):334-343, 18 Dec 2023
Cited by: 1 article | PMID: 38110620 | PMCID: PMC10961739
Add to export list Free full text in Europe PMC
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102.
Saber W, Bansal A, Li L, Scott BL, Sangaralingham LR, Thao V, Roth JA, Wright W, Steuten LMG, Pidala JA, Mishra A, Maziarz RT, Westervelt P, McGuirk JP, Cutler C, Nakamura R, Ramsey SD
JCO Oncol Pract, 20(4):572-580, 23 Jan 2024
Cited by: 1 article | PMID: 38261970
Add to export list
A new beginning: can omidubicel emerge as the next, viable alternative donor source?
Gandhi AP, Newell LF, Maziarz RT
Ther Adv Hematol, 14:20406207231192146, 30 Aug 2023
Cited by: 1 article | PMID: 37664800 | PMCID: PMC10469227
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Can we truly define 'Fitness' for CAR-T therapy in large B cell lymphoma patients?
Chen AI, Maziarz RT
Chin Clin Oncol, 13(1):15, 24 Oct 2023
Cited by: 0 articles | PMID: 37953244
Add to export list
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
Meyers G, Hamadani M, Martens M, Ali H, Chevallier P, Choe H, Harris AC, Holler E, van Hooren E, Klaassen W, Leifer E, van Oosterhout Y, Perez L, Pusic I, Stelljes M, van der Velden W, Ammatuna E, Beauvais D, Cornillon J, [...] Socié G
Bone Marrow Transplant, 58(12):1416-1418, 25 Sep 2023
Cited by: 2 articles | PMID: 37749187
Add to export list
Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial.
Majhail NS, Miller B, Dean R, Manghani R, Shin H, Sivaraman S, Maziarz RT
Transplant Cell Ther, 29(12):749.e1-749.e5, 12 Sep 2023
Cited by: 1 article | PMID: 37703995
Add to export list
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma.
Scordo M, Flynn JR, Gonen M, Devlin SM, Parascondola A, Tomas AA, Shouval R, Brower J, Porter DL, Schuster SJ, Bachanova V, Maakaron J, Maziarz RT, Chen AI, Nastoupil LJ, McGuirk JP, Oluwole OO, Ip A, Leslie LA, [...] Perales MA
Blood Adv, 7(18):5579-5585, 01 Sep 2023
Cited by: 7 articles | PMID: 37522731 | PMCID: PMC10514205
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome.
Bhaskar ST, Patel VG, Porter DL, Schuster SJ, Nastoupil LJ, Perales MA, Tomas AA, Bishop MR, McGuirk JP, Maziarz RT, Chen AI, Bachanova V, Maakaron JE, Riedell PA, Oluwole OO
Blood Adv, 7(17):4765-4772, 01 Sep 2023
Cited by: 4 articles | PMID: 36508286 | PMCID: PMC10468356
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.
Versluis J, Saber W, Tsai HK, Gibson CJ, Dillon LW, Mishra A, McGuirk J, Maziarz RT, Westervelt P, Hegde P, Mukherjee D, Martens MJ, Logan B, Horowitz M, Hourigan CS, Nakamura R, Cutler C, Lindsley RC, Blood and Marrow Transplant Clinical Trials Network
J Clin Oncol, 41(28):4497-4510, 22 Aug 2023
Cited by: 5 articles | PMID: 37607457 | PMCID: PMC10552956
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient.
Maziarz RT, Devine S, Garrison LP, Agodoa I, Badaracco J, Gitlin M, Perales MA
Transplant Cell Ther, 29(10):637.e1-637.e9, 24 Jun 2023
Cited by: 2 articles | PMID: 37364775
Add to export list
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.
Wudhikarn K, Tomas AA, Flynn JR, Devlin SM, Brower J, Bachanova V, Nastoupil LJ, McGuirk JP, Maziarz RT, Oluwole OO, Schuster SJ, Porter DL, Bishop MR, Riedell PA, Perales MA
Blood Adv, 7(13):3192-3198, 01 Jul 2023
Cited by: 13 articles | PMID: 36355838 | PMCID: PMC10338201
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques.
Wu HL, Busman-Sahay K, Weber WC, Waytashek CM, Boyle CD, Bateman KB, Reed JS, Hwang JM, Shriver-Munsch C, Swanson T, Northrup M, Armantrout K, Price H, Robertson-LeVay M, Uttke S, Kumar MR, Fray EJ, Taylor-Brill S, Bondoc S, [...] Sacha JB
Immunity, 56(7):1649-1663.e5, 25 May 2023
Cited by: 13 articles | PMID: 37236188 | PMCID: PMC10524637
Add to export list Free full text in Europe PMC
A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation.
Bubalo JS, Radke JL, Bensch KG, Chen AI, Misra S, Maziarz RT
J Oncol Pharm Pract, 30(2):304-312, 07 May 2023
Cited by: 2 articles | PMID: 37151021
Add to export list
A retrospective single-center analysis of CD-19 directed CAR T-cell therapy in relapsed/refractory mantle cell lymphoma.
Banerjee T, Newman M, Chen A, Maziarz RT, Schachter L, Spurgeon SE, Vallurupalli A
Leuk Lymphoma, 64(8):1472-1475, 07 Jun 2023
Cited by: 2 articles | PMID: 37287113
Add to export list
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma.
Ahmed N, Wesson W, Mushtaq MU, Porter DL, Nasta SD, Brower J, Bachanova V, Hu M, Nastoupil LJ, Oluwole OO, Patel VG, Oliai C, Riedell PA, Bishop MR, Shah GL, Perales MA, Schachter L, Maziarz RT, McGuirk JP
Transplant Cell Ther, 29(7):449.e1-449.e7, 27 Apr 2023
Cited by: 5 articles | PMID: 37120134
Add to export list Review

1-25 of 286 results

1 2 3 Next ...

Search life-sciences literature (45,103,477 articles, preprints and more)

Search results

Partnerships & funding